144 related articles for article (PubMed ID: 16981190)
1. Elasticities of market shares and social health insurance choice in Germany: a dynamic panel data approach.
Tamm M; Tauchmann H; Wasem J; Gress S
Health Econ; 2007 Mar; 16(3):243-56. PubMed ID: 16981190
[TBL] [Abstract][Full Text] [Related]
2. Effects of the German reference drug program on ex-factory prices of prescription drugs: a panel data approach.
Augurzky B; Göhlmann S; Gress S; Wasem J
Health Econ; 2009 Apr; 18(4):421-36. PubMed ID: 18677725
[TBL] [Abstract][Full Text] [Related]
3. Pricing behaviour of nonprofit insurers in a weakly competitive social health insurance market.
Douven RC; Schut FT
J Health Econ; 2011 Mar; 30(2):439-49. PubMed ID: 21295365
[TBL] [Abstract][Full Text] [Related]
4. Health insurance and imperfect competition in the health care market.
Vaithianathan R
J Health Econ; 2006 Nov; 25(6):1193-202. PubMed ID: 16647770
[TBL] [Abstract][Full Text] [Related]
5. Price elasticities in the German Statutory Health Insurance market before and after the health care reform of 2009.
Pendzialek JB; Danner M; Simic D; Stock S
Health Policy; 2015 May; 119(5):654-63. PubMed ID: 25670009
[TBL] [Abstract][Full Text] [Related]
6. Effects of cost sharing on physician utilization under favourable conditions for supplier-induced demand.
Van de Voorde C; Van Doorslaer E; Schokkaert E
Health Econ; 2001 Jul; 10(5):457-71. PubMed ID: 11466806
[TBL] [Abstract][Full Text] [Related]
7. Risk selection in the German public health insurance system.
Nuscheler R; Knaus T
Health Econ; 2005 Dec; 14(12):1253-71. PubMed ID: 15942977
[TBL] [Abstract][Full Text] [Related]
8. Managed competition and consumer price sensitivity in social health insurance.
Schut FT; Hassink WH
J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
[TBL] [Abstract][Full Text] [Related]
9. Has cost containment after the National Health Insurance system been successful? Determinants of Taiwan hospital costs.
Hung JH; Chang L
Health Policy; 2008 Mar; 85(3):321-35. PubMed ID: 17949848
[TBL] [Abstract][Full Text] [Related]
10. Optional deductibles in social health insurance systems: findings from Germany.
Pütz C; Hagist C
Eur J Health Econ; 2006 Dec; 7(4):225-30. PubMed ID: 16802119
[TBL] [Abstract][Full Text] [Related]
11. Is the medical loss ratio a good target measure for regulation in the individual market for health insurance?
Karaca-Mandic P; Abraham JM; Simon K
Health Econ; 2015 Jan; 24(1):55-74. PubMed ID: 24123608
[TBL] [Abstract][Full Text] [Related]
12. Supervision in social health insurance: a four country study.
Maarse H; Paulus A; Kuiper G
Health Policy; 2005 Mar; 71(3):333-46. PubMed ID: 15694500
[TBL] [Abstract][Full Text] [Related]
13. The demand for physician services. Evidence from a natural experiment.
Cockx B; Brasseur C
J Health Econ; 2003 Nov; 22(6):881-913. PubMed ID: 14604552
[TBL] [Abstract][Full Text] [Related]
14. [Does co-operation research provide approaches to explain the changes in the German hospital market?].
Raible C; Leidl R
Gesundheitswesen; 2004 Nov; 66(11):707-15. PubMed ID: 15562340
[TBL] [Abstract][Full Text] [Related]
15. Is there a business case for quality in The Netherlands? A critical analysis of the recent reforms of the health care system.
Custers T; Arah OA; Klazinga NS
Health Policy; 2007 Jul; 82(2):226-39. PubMed ID: 17070956
[TBL] [Abstract][Full Text] [Related]
16. Transferring the burden of risk in private health care: medical indemnity insurance reform.
Patterson RM
J Law Med; 2003 Nov; 11(2):214-29. PubMed ID: 14655585
[TBL] [Abstract][Full Text] [Related]
17. Methods for determining cost-benefit ratios for pharmaceuticals in Germany.
von der Schulenburg J; Vauth C; Mittendorf T; Greiner W
Eur J Health Econ; 2007 Sep; 8 Suppl 1():S5-31. PubMed ID: 17582539
[TBL] [Abstract][Full Text] [Related]
18. Consumer price sensitivity in Dutch health insurance.
van Dijk M; Pomp M; Douven R; Laske-Aldershof T; Schut E; de Boer W; de Boo A
Int J Health Care Finance Econ; 2008 Dec; 8(4):225-44. PubMed ID: 18709549
[TBL] [Abstract][Full Text] [Related]
19. Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany.
Stargardt T; Schreyögg J; Busse R
Health Policy; 2007 Nov; 84(1):30-8. PubMed ID: 17553587
[TBL] [Abstract][Full Text] [Related]
20. The medical technology industry: a competence centre for health.
Schmitt JM; Beeres M
Med Device Technol; 2006 Apr; 17(3):52-3. PubMed ID: 16736668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
